Stock vs Stock Comparison

Johnson & Johnson vs UnitedHealth Group Incorporated

JNJ wins the Tale of the Tape 6–3.

JNJ$222.89
UNH$377.92

🏆 Tale of the Tape

63
JNJUNH
28.5%Profitability (Net Margin)2.7%
26.1xValuation (P/E)28.7x
18.3%Efficiency (ROIC)7.6%
4/9Health (Piotroski F)6/9
4.0Safety (Altman Z)2.8
6.0%Growth (Rev YoY)11.8%
2.69Risk (Sharpe 1Y)-0.96
1.44xBalance Sheet (D/E)2.04x
3.25%FCF Yield4.96%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.054
252-Day Correlation
-0.047
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricJNJUNH
Market Cap$542.4B$345.4B
P/E Ratio26.1x28.7x
Forward P/E17.7x18.2x
P/B6.68x3.53x
Dividend Yield2.38%2.32%
Beta0.260.65

Quantitative Metrics

MetricJNJUNH
DCF Fair Value$134.24$250.41
DCF Upside-43.6%-20.0%
Piotroski F4/96/9
Altman Z3.972.78
Beneish M-2.27-2.42
FCF Yield3.25%4.96%
Net Debt/EBITDA0.5x2.1x
ROIC18.3%7.6%
WACC7.7%7.2%
ROIC – WACC10.5pp0.4pp
Gross Margin67.9%18.5%
Net Margin28.5%2.7%
Rev Growth YoY6.0%11.8%
Sharpe (1Y)2.69-0.96
Max Drawdown 3Y-16.0%
FCF Payout Ratio64%49%

JNJ Price

Loading chart...

UNH Price

Loading chart...

ETF Exposure

JNJ found in:

XLV10.42%
IYH10.14%
VHT8.84%
HDV6.84%
MTUM3.76%
DIA2.83%
MGV2.75%
DGRO2.64%
VIG2.49%
VYM2.30%
VTV2.16%
DGRW2.02%
SCHV2.02%
IWD1.94%
QUS1.81%
XPH1.74%
VONV1.69%
NOBL1.58%
VFMV1.42%
VFMO1.02%
SCHX0.96%
SPYG0.94%
SDY0.93%
VOO0.90%
SCHB0.90%
SPY0.87%
IVV0.85%
VONE0.84%
SPTM0.81%
VTI0.80%
SPYV0.79%
SPLG0.76%
ITOT0.75%
URTH0.70%
ACWI0.57%
VT0.49%
RSP0.21%
VFVA0.15%
ONEO0.05%

UNH found in:

XLV6.47%
IYH6.18%
VHT5.43%
DIA4.68%
DGRW2.47%
XHS2.41%
DGRO2.31%
MGV1.66%
VIG1.51%
VYM1.40%
VTV1.31%
QUS1.22%
SPYV1.20%
VONV1.03%
SCHG1.01%
IWD0.81%
VFVA0.63%
SPLG0.55%
SPY0.54%
VOO0.54%
IVV0.51%
VONE0.51%
SPTM0.50%
ESGV0.50%
VTI0.48%
ITOT0.45%
SCHX0.43%
SCHB0.40%
URTH0.31%
VT0.30%
ACWI0.27%
RSP0.17%
ONEO0.02%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

JNJ vs UNH: Head-to-Head Analysis

Johnson & Johnson (JNJ) and UnitedHealth Group Incorporated (UNH) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, JNJ leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, JNJ generates a return on invested capital (ROIC) of 18.3% compared to UNH's 7.6%. This suggests JNJ is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between JNJ and UNH is 0.054, indicating low correlation, making them an effective diversification pair in a portfolio context.

JNJ appears in 39 ETFs tracked by SecuritiesDB, while UNH appears in 33 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, JNJ or UNH?

Our quantitative analysis compares JNJ and UNH across nine fundamental dimensions. JNJ wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are JNJ and UNH correlated?

The 252-day correlation between JNJ and UNH is 0.054. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.